Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient's cells.
A research team has discovered that accumulated DNA damage in the retina is a key contributor to age-related macular degeneration and that targeting specific retinal cell types may lead to treatments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results